Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Home Monitoring of Patients With a Predicted Mild Acute Pancreatitis - A Feasibility Study (REMAP)

NCT05501314 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT05501314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05501314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Home Monitoring of Patients With a Predicted Mild Acute Pancreatitis - A Feasibility Study (REMAP)
Lead sponsor
Rijnstate Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2022
Completion date
April 30, 2025
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis, healthdot, monitoring, patient discharge, telemedicine